Michael Stapelberg

659 total citations
15 papers, 484 citations indexed

About

Michael Stapelberg is a scholar working on Oncology, Dermatology and Biotechnology. According to data from OpenAlex, Michael Stapelberg has authored 15 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Dermatology and 4 papers in Biotechnology. Recurrent topics in Michael Stapelberg's work include Skin Protection and Aging (4 papers), Cancer Research and Treatments (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Michael Stapelberg is often cited by papers focused on Skin Protection and Aging (4 papers), Cancer Research and Treatments (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Michael Stapelberg collaborates with scholars based in Australia, Czechia and Italy. Michael Stapelberg's co-authors include Gary M. Halliday, Jiřı́ Neužil, Joohong Park, Diona L. Damian, Ross St.C. Barnetson, Marco Tomasetti, Nina Gellert, Emma Swettenham, Antonio Domenico Procopio and Lan‐Feng Dong and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Michael Stapelberg

15 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Stapelberg Australia 10 188 124 93 85 63 15 484
Dominik Stuhlmann Germany 13 339 1.8× 59 0.5× 90 1.0× 90 1.1× 34 0.5× 19 649
Anthie Yiakouvaki United Kingdom 9 406 2.2× 36 0.3× 112 1.2× 113 1.3× 39 0.6× 9 615
Jian-Li Huang China 9 230 1.2× 72 0.6× 91 1.0× 51 0.6× 59 0.9× 14 413
Rabindranath Bera India 12 265 1.4× 138 1.1× 79 0.8× 70 0.8× 22 0.3× 19 619
Valerio Ciccone Italy 16 242 1.3× 21 0.2× 145 1.6× 128 1.5× 72 1.1× 44 618
Sung Yong Choi South Korea 13 132 0.7× 34 0.3× 56 0.6× 38 0.4× 56 0.9× 29 485
Serpil Oğuztüzün Türkiye 11 188 1.0× 53 0.4× 55 0.6× 71 0.8× 26 0.4× 53 438
Jiao Xue China 11 333 1.8× 19 0.2× 83 0.9× 142 1.7× 62 1.0× 24 519
Hiromi Mizuno Japan 12 123 0.7× 18 0.1× 66 0.7× 58 0.7× 24 0.4× 19 404
Yong Qing China 15 317 1.7× 48 0.4× 86 0.9× 49 0.6× 18 0.3× 43 557

Countries citing papers authored by Michael Stapelberg

Since Specialization
Citations

This map shows the geographic impact of Michael Stapelberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Stapelberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Stapelberg more than expected).

Fields of papers citing papers by Michael Stapelberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Stapelberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Stapelberg. The network helps show where Michael Stapelberg may publish in the future.

Co-authorship network of co-authors of Michael Stapelberg

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Stapelberg. A scholar is included among the top collaborators of Michael Stapelberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Stapelberg. Michael Stapelberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
2.
Climstein, Mike, Michael Stapelberg, Ian Miller, et al.. (2024). Patients poorly recognize lesions of concern that are malignant melanomas: is self-screening the correct advice?. PeerJ. 12. e17674–e17674. 2 indexed citations
3.
Miller, Ian, Nedeljka Rosić, Michael Stapelberg, et al.. (2024). Performance of Commercial Dermatoscopic Systems That Incorporate Artificial Intelligence for the Identification of Melanoma in General Practice: A Systematic Review. Cancers. 16(7). 1443–1443. 8 indexed citations
4.
Miller, Ian, Michael Stapelberg, Nedeljka Rosić, et al.. (2023). Implementation of artificial intelligence for the detection of cutaneous melanoma within a primary care setting: prevalence and types of skin cancer in outdoor enthusiasts. PeerJ. 11. e15737–e15737. 6 indexed citations
5.
Climstein, Mike, Michael Stapelberg, Nedeljka Rosić, et al.. (2022). Point prevalence of non-melanoma and melanoma skin cancers in Australian surfers and swimmers in Southeast Queensland and Northern New South Wales. PeerJ. 10. e13243–e13243. 9 indexed citations
6.
Budzinska, Magdalena A., James G. Kench, Michael Stapelberg, et al.. (2019). Virus Genotype-Dependent Transcriptional Alterations in Lipid Metabolism and Inflammation Pathways in the Hepatitis C Virus-infected Liver. Scientific Reports. 9(1). 10596–10596. 19 indexed citations
7.
Yan, Bing, Marina Stantic, Renata Zobalová, et al.. (2015). Mitochondrially targeted vitamin E succinate efficiently kills breast tumour-initiating cells in a complex II-dependent manner. BMC Cancer. 15(1). 401–401. 56 indexed citations
8.
Truksa, Jaroslav, Lan‐Feng Dong, Jakub Rohlena, et al.. (2015). Mitochondrially Targeted Vitamin E Succinate Modulates Expression of Mitochondrial DNA Transcripts and Mitochondrial Biogenesis. Antioxidants and Redox Signaling. 22(11). 883–900. 38 indexed citations
9.
Stapelberg, Michael, Martina Bajzíková, Marina Stantic, et al.. (2015). Characterisation of Mesothelioma-Initiating Cells and Their Susceptibility to Anti-Cancer Agents. PLoS ONE. 10(5). e0119549–e0119549. 22 indexed citations
10.
Zobalová, Renata, Marina Stantic, Michael Stapelberg, et al.. (2011). The Potential Role of CD133 in Immune Surveillance and Apoptosis: A Mitochondrial Connection?. Antioxidants and Redox Signaling. 15(12). 2989–3002. 7 indexed citations
11.
Stapelberg, Michael, Rohan B. H. Williams, Scott N. Byrne, & Gary M. Halliday. (2009). The Alternative Complement Pathway Seems to be a UVA Sensor that Leads to Systemic Immunosuppression. Journal of Investigative Dermatology. 129(11). 2694–2701. 29 indexed citations
12.
Neužil, Jiřı́, Emma Swettenham, Xiufang Wang, Lan‐Feng Dong, & Michael Stapelberg. (2007). α‐Tocopheryl succinate inhibits angiogenesis by disrupting paracrine FGF2 signalling. FEBS Letters. 581(24). 4611–4615. 16 indexed citations
13.
Damian, Diona L., et al.. (2007). UV Radiation-Induced Immunosuppression Is Greater in Men and Prevented by Topical Nicotinamide. Journal of Investigative Dermatology. 128(2). 447–454. 157 indexed citations
14.
Stapelberg, Michael, Nina Gellert, Emma Swettenham, et al.. (2005). α-Tocopheryl Succinate Inhibits Malignant Mesothelioma byDisrupting the Fibroblast Growth Factor Autocrine Loop. Journal of Biological Chemistry. 280(27). 25369–25376. 94 indexed citations
15.
Stapelberg, Michael, Marco Tomasetti, Renata Alleva, et al.. (2004). α-Tocopheryl succinate inhibits proliferation of mesothelioma cells by selective down-regulation of fibroblast growth factor receptors. Biochemical and Biophysical Research Communications. 318(3). 636–641. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026